» Articles » PMID: 30854037

Identification and Characterization of Dysregulated P-element Induced Wimpy Testis-interacting RNAs in Head and Neck Squamous Cell Carcinoma

Overview
Journal Oncol Lett
Specialty Oncology
Date 2019 Mar 12
PMID 30854037
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

It is clear that alcohol consumption is a major risk factor in the pathogenesis of head and neck squamous cell carcinoma (HNSCC); however, the molecular mechanism underlying the pathogenesis of alcohol-associated HNSCC remains poorly understood. The aim of the present study was to identify and characterize P-element-induced wimpy testis (PIWI)-interacting RNAs (piRNAs) and PIWI proteins dysregulated in alcohol-associated HNSCC to elucidate their function in the development of this cancer. Using next generation RNA-sequencing (RNA-seq) data obtained from 40 HNSCC patients, the piRNA and PIWI protein expression of HNSCC samples was compared between alcohol drinkers and non-drinkers. A separate piRNA expression RNA-seq analysis of 18 non-smoker HNSCC patients was also conducted. To verify piRNA expression, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed on the most differentially expressed alcohol-associated piRNAs in ethanol and acetaldehyde-treated normal oral keratinocytes. The correlation between piRNA expression and patient survival was analyzed using Kaplan-Meier estimators and multivariate Cox proportional hazard models. A comparison between alcohol drinking and non-drinking HNSCC patients demonstrated that a panel of 3,223 piRNA transcripts were consistently detected and differentially expressed. RNA-seq analysis and RT-qPCR verification revealed that 4 of these piRNAs, piR-35373, piR-266308, piR-58510 and piR-38034, were significantly dysregulated between drinking and non-drinking cohorts. Of these four piRNAs, low expression of piR-58510 and piR-35373 significantly correlated with improved patient survival. Furthermore, human PIWI-like protein 4 was consistently upregulated in ethanol and acetaldehyde-treated normal oral keratinocytes. These results demonstrate that alcohol consumption may cause dysregulation of piRNA expression in HNSCC and verifications identified 4 piRNAs that may be involved in the pathogenesis of alcohol-associated HNSCC.

Citing Articles

Non-coding RNAs in oral cancer: Emerging biomarkers and therapeutic frontier.

Hashemi M, Khoushab S, Hobabi Aghmiuni M, Anaraki S, Alimohammadi M, Taheriazam A Heliyon. 2024; 10(21):e40096.

PMID: 39583806 PMC: 11582460. DOI: 10.1016/j.heliyon.2024.e40096.


PIWI-interacting RNAs (PiRNAs) as emerging biomarkers and therapeutic targets in biliary tract cancers: A comprehensive review.

Ahmadi Asouri S, Aghadavood E, Mirzaei H, Abaspour A, Shahaboddin M Heliyon. 2024; 10(13):e33767.

PMID: 39040379 PMC: 11261894. DOI: 10.1016/j.heliyon.2024.e33767.


The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis).

Taghizadeh M, Jafari-Koshki T, Jafarlou V, Raeisi M, Alizadeh L, Roosta Y BMC Cancer. 2024; 24(1):484.

PMID: 38627675 PMC: 11022431. DOI: 10.1186/s12885-024-12180-2.


Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications.

Dey S, Biswas B, Manoj Appadan A, Shah J, Pal J, Basu S Cancers (Basel). 2023; 15(15).

PMID: 37568568 PMC: 10417002. DOI: 10.3390/cancers15153752.


Noncoding RNAs in oral cancer.

Balakittnen J, Weeramange C, Wallace D, Duijf P, Cristino A, Kenny L Wiley Interdiscip Rev RNA. 2022; 14(3):e1754.

PMID: 35959932 PMC: 10909450. DOI: 10.1002/wrna.1754.


References
1.
Homann N, Tillonen J, Meurman J, Rintamaki H, Lindqvist C, Rautio M . Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis. 2000; 21(4):663-8. DOI: 10.1093/carcin/21.4.663. View

2.
Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

3.
Nemunaitis J, OBrien J . Head and neck cancer: gene therapy approaches. Part 1: adenoviral vectors. Expert Opin Biol Ther. 2002; 2(2):177-85. DOI: 10.1517/14712598.2.2.177. View

4.
Sturgis E, Wei Q, Spitz M . Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol. 2004; 31(6):726-33. DOI: 10.1053/j.seminoncol.2004.09.013. View

5.
Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View